Potential Non-coding RNAs from Microorganisms and their Therapeutic Use in the Treatment of Different Human Cancers

Author(s): Raju Biswas, Dipanjana Ghosh, Bhramar Dutta, Urmi Halder, Prittam Goswami, Rajib Bandopadhyay*

Journal Name: Current Gene Therapy

Volume 21 , Issue 3 , 2021

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Cancer therapy describes the treatment of cancer, often with surgery, chemotherapy, and radiotherapy. Additionally, RNA interference (RNAi) is likely to be considered a new emerging, alternative therapeutic approach for silencing/targeting cancer-related genes. RNAi can exert antiproliferative and proapoptotic effects by targeting functional carcinogenic molecules or knocking down gene products of cancer-related genes. However, in contrast to conventional cancer therapies, RNAi based therapy seems to have fewer side effects. Transcription signal sequence and conserved sequence analysis-showed that microorganisms could be a potent source of non-coding RNAs. This review concluded that mapping of RNAi mechanism and RNAi based drug delivery approaches is expected to lead a better prospective of cancer therapy.

Keywords: Cancer therapy, RNA interference, carcinogenic, microorganisms, drugs delivery, RNAi based therapy.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 30 December, 2020
Page: [207 - 215]
Pages: 9
DOI: 10.2174/1566523220999201230204814
Price: $65

Article Metrics

PDF: 267